| 1 |
Lin G, Zhou J, Cheng H, Liu G. Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges. Small 2023. [DOI: 10.1002/smll.202207973] [Reference Citation Analysis]
|
| 2 |
Sun B, Lovell JF, Zhang Y. Current development of cabazitaxel drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2023;15:e1854. [PMID: 36161272 DOI: 10.1002/wnan.1854] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Tanaka HY, Nakazawa T, Enomoto A, Masamune A, Kano MR. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment. Cancers (Basel) 2023;15. [PMID: 36765684 DOI: 10.3390/cancers15030724] [Reference Citation Analysis]
|
| 4 |
Tatar A, Nagy-simon T, Tigu AB, Tomuleasa C, Boca S. Optimization of tyrosine kinase inhibitor-loaded gold nanoparticles for stimuli-triggered antileukemic drug release.. [DOI: 10.21203/rs.3.rs-2314501/v1] [Reference Citation Analysis]
|
| 5 |
Pallavi P, Harini K, Gowtham P, Girigoswami K, Girigoswami A. Fabrication of Polymersomes: A Macromolecular Architecture in Nanotherapeutics. Chemistry 2022;4:1028-1043. [DOI: 10.3390/chemistry4030070] [Reference Citation Analysis]
|
| 6 |
Dessale M, Mengistu G, Mengist HM. Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis. Int J Nanomedicine 2022;17:3735-49. [PMID: 36051353 DOI: 10.2147/IJN.S378074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Yang P, Qu Y, Wang M, Chu B, Chen W, Zheng Y, Niu T, Qian Z. Pathogenesis and treatment of multiple myeloma. MedComm (2020) 2022;3:e146. [PMID: 35665368 DOI: 10.1002/mco2.146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Liu Y, Han Y, Chen S, Liu J, Wang D, Huang Y. Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma. Acta Pharmaceutica Sinica B 2022;12:2731-9. [DOI: 10.1016/j.apsb.2021.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Shao R, Wang Y, Li L, Dong Y, Zhao J, Liang W. Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations. Drug Deliv 2022;29:1631-47. [PMID: 35612368 DOI: 10.1080/10717544.2022.2075983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Luo YL, Zhang HY, Li GK, Zhao YY, Yang Y, Rong RX, Li XL, Wang KR. Synthesis, Renal Clearance, and Photothermal Therapy Based on the Self-Assembly of a Nanomedicine Consisting of Quaterrylene Bisimide and Glycocluster Conjugates. ACS Macro Lett 2022;11:615-21. [PMID: 35570815 DOI: 10.1021/acsmacrolett.2c00093] [Reference Citation Analysis]
|
| 11 |
Chu S, Shi X, Tian Y, Gao F. pH-Responsive Polymer Nanomaterials for Tumor Therapy. Front Oncol 2022;12:855019. [PMID: 35392227 DOI: 10.3389/fonc.2022.855019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 12 |
Sharifi-Rad J, Quispe C, Patra JK, Singh YD, Panda MK, Das G, Adetunji CO, Michael OS, Sytar O, Polito L, Živković J, Cruz-Martins N, Klimek-Szczykutowicz M, Ekiert H, Choudhary MI, Ayatollahi SA, Tynybekov B, Kobarfard F, Muntean AC, Grozea I, Daştan SD, Butnariu M, Szopa A, Calina D. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy. Oxid Med Cell Longev 2021;2021:3687700. [PMID: 34707776 DOI: 10.1155/2021/3687700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 13 |
Song S, Peng J, Wu Y, Li C, Shen D, Yang G, Liu J, Gong P, Liu Z. Biomimetic synthesis of a novel O2-regeneration nanosystem for enhanced starvation/chemo-therapy. Nanotechnology 2021;33. [PMID: 34544066 DOI: 10.1088/1361-6528/ac2843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Nehra M, Uthappa UT, Kumar V, Kumar R, Dixit C, Dilbaghi N, Mishra YK, Kumar S, Kaushik A. Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner. J Control Release 2021;338:224-43. [PMID: 34418523 DOI: 10.1016/j.jconrel.2021.08.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 15 |
Rinoldi C, Zargarian SS, Nakielski P, Li X, Liguori A, Petronella F, Presutti D, Wang Q, Costantini M, De Sio L, Gualandi C, Ding B, Pierini F. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines. Small Methods 2021;5:2100402. [PMID: 34514087 DOI: 10.1002/smtd.202100402] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 16 |
Levit SL, Tang C. Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer. Nanomaterials (Basel) 2021;11:1048. [PMID: 33923947 DOI: 10.3390/nano11041048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 17 |
Zhong J, Zhang Q, Zhang Z, Shi K, Sun Y, Liu T, Lin J, Yang K. Albumin mediated reactive oxygen species scavenging and targeted delivery of methotrexate for rheumatoid arthritis therapy. Nano Res 2022;15:153-61. [DOI: 10.1007/s12274-021-3449-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 18 |
Liao J, Han R, Wu Y, Qian Z. Review of a new bone tumor therapy strategy based on bifunctional biomaterials. Bone Res 2021;9:18. [PMID: 33727543 DOI: 10.1038/s41413-021-00139-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 36.5] [Reference Citation Analysis]
|
| 19 |
Wei X, Zhong M, Wang S, Li L, Song ZL, Zhang J, Xu J, Fang J. Synthesis and biological evaluation of disulfides as anticancer agents with thioredoxin inhibition. Bioorg Chem 2021;110:104814. [PMID: 33756234 DOI: 10.1016/j.bioorg.2021.104814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Jia W, Wang Y, Liu R, Yu X, Gao H. Shape Transformable Strategies for Drug Delivery. Adv Funct Mater 2021;31:2009765. [DOI: 10.1002/adfm.202009765] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 21 |
Chen Y, Pan Y, Hu D, Peng J, Hao Y, Pan M, Yuan L, Yu Y, Qian Z. Recent progress in nanoformulations of cabazitaxel. Biomed Mater 2021. [PMID: 33545700 DOI: 10.1088/1748-605X/abe396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Morey J, Llinás P, Bueno-Costa A, León AJ, Piña MN. Raltitrexed-Modified Gold and Silver Nanoparticles for Targeted Cancer Therapy: Cytotoxicity Behavior In Vitro on A549 and HCT-116 Human Cancer Cells. Materials (Basel) 2021;14:534. [PMID: 33499297 DOI: 10.3390/ma14030534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Mhaske A, Dighe S, Ghosalkar S, Tanna V, Ravikumar P, Sawarkar SP. Limitations of Current Cancer Theranostics. Nanotechnology in the Life Sciences 2021. [DOI: 10.1007/978-3-030-76263-6_12] [Reference Citation Analysis]
|
| 24 |
Alshehri S, Imam SS, Rizwanullah M, Akhter S, Mahdi W, Kazi M, Ahmad J. Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges. Pharmaceutics 2020;13:E24. [PMID: 33374391 DOI: 10.3390/pharmaceutics13010024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 25 |
Barnoy EA, Popovtzer R, Fixler D. Fluorescence for biological logic gates. J Biophotonics 2020;13:e202000158. [PMID: 32537894 DOI: 10.1002/jbio.202000158] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 26 |
Thorat ND, Townley HE, Patil RM, Tofail SAM, Bauer J. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer. Drug Discov Today 2020;25:1245-52. [PMID: 32371139 DOI: 10.1016/j.drudis.2020.04.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 27 |
Sevencan C, Mccoy RSA, Ravisankar P, Liu M, Govindarajan S, Zhu J, Bay BH, Leong DT. Cell Membrane Nanotherapeutics: From Synthesis to Applications Emerging Tools for Personalized Cancer Therapy. Adv Therap 2020;3:1900201. [DOI: 10.1002/adtp.201900201] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
|
